IRIS Accounts Production v24.3.2.46 10634899 director 1.3.24 28.2.25 28.2.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh106348992024-02-29106348992025-02-28106348992024-03-012025-02-28106348992023-02-28106348992023-03-012024-02-29106348992024-02-2910634899ns15:EnglandWales2024-03-012025-02-2810634899ns14:PoundSterling2024-03-012025-02-2810634899ns10:Director12024-03-012025-02-2810634899ns10:PrivateLimitedCompanyLtd2024-03-012025-02-2810634899ns10:SmallEntities2024-03-012025-02-2810634899ns10:AuditExempt-NoAccountantsReport2024-03-012025-02-2810634899ns10:SmallCompaniesRegimeForDirectorsReport2024-03-012025-02-2810634899ns10:SmallCompaniesRegimeForAccounts2024-03-012025-02-2810634899ns10:FullAccounts2024-03-012025-02-2810634899ns10:RegisteredOffice2024-03-012025-02-2810634899ns5:CurrentFinancialInstruments2025-02-2810634899ns5:CurrentFinancialInstruments2024-02-2910634899ns5:ShareCapital2025-02-2810634899ns5:ShareCapital2024-02-2910634899ns5:RetainedEarningsAccumulatedLosses2025-02-2810634899ns5:RetainedEarningsAccumulatedLosses2024-02-2910634899ns5:FurnitureFittings2024-03-012025-02-2810634899ns5:ComputerEquipment2024-03-012025-02-2810634899ns5:FurnitureFittings2024-02-2910634899ns5:ComputerEquipment2024-02-2910634899ns5:FurnitureFittings2025-02-2810634899ns5:ComputerEquipment2025-02-2810634899ns5:FurnitureFittings2024-02-2910634899ns5:ComputerEquipment2024-02-2910634899ns5:WithinOneYearns5:CurrentFinancialInstruments2025-02-2810634899ns5:WithinOneYearns5:CurrentFinancialInstruments2024-02-29
REGISTERED NUMBER: 10634899 (England and Wales)














Unaudited Financial Statements for the Year Ended 28 February 2025

for

Specialised Neuroimaging Reporting
London Limited

Specialised Neuroimaging Reporting
London Limited (Registered number: 10634899)






Contents of the Financial Statements
for the Year Ended 28 February 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Specialised Neuroimaging Reporting
London Limited

Company Information
for the Year Ended 28 February 2025







DIRECTOR: Dr C Micallef





REGISTERED OFFICE: 8 Coldbath Square
London
London
EC1R 5HL





REGISTERED NUMBER: 10634899 (England and Wales)





ACCOUNTANTS: Nordens
The Retreat
406 Roding Lane South
Woodford Green
Essex
IG8 8EY

Specialised Neuroimaging Reporting
London Limited (Registered number: 10634899)

Balance Sheet
28 February 2025

28.2.25 29.2.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,604 3,592

CURRENT ASSETS
Debtors 5 60,017 58,703
Investments 6 50,500 -
Cash at bank 62,302 69,037
172,819 127,740
CREDITORS
Amounts falling due within one year 7 16,268 14,079
NET CURRENT ASSETS 156,551 113,661
TOTAL ASSETS LESS CURRENT LIABILITIES 159,155 117,253

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 159,153 117,251
SHAREHOLDERS' FUNDS 159,155 117,253

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 4 April 2025 and were signed by:




Dr C Micallef - Director


Specialised Neuroimaging Reporting
London Limited (Registered number: 10634899)

Notes to the Financial Statements
for the Year Ended 28 February 2025

1. STATUTORY INFORMATION

Specialised Neuroimaging Reporting London Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on cost
Computer equipment - 25% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - 1 ) .

Specialised Neuroimaging Reporting
London Limited (Registered number: 10634899)

Notes to the Financial Statements - continued
for the Year Ended 28 February 2025

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 March 2024 11,912 7,253 19,165
Additions - 1,238 1,238
At 28 February 2025 11,912 8,491 20,403
DEPRECIATION
At 1 March 2024 8,979 6,594 15,573
Charge for year 1,587 639 2,226
At 28 February 2025 10,566 7,233 17,799
NET BOOK VALUE
At 28 February 2025 1,346 1,258 2,604
At 29 February 2024 2,933 659 3,592

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
28.2.25 29.2.24
£    £   
Other debtors 60,017 58,703

6. CURRENT ASSET INVESTMENTS
28.2.25 29.2.24
£    £   
Unlisted investments 50,500 -

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
28.2.25 29.2.24
£    £   
Taxation and social security 15,074 12,903
Other creditors 1,194 1,176
16,268 14,079